COVID-19 Impact on Vaccines Market By Key Manufacturers, By Technology (Conjugate Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccines), By Indication (Pneumococcal Disease, Influenza, Human Papilloma Virus, Meningococcal Disease, Rotavirus, Varicella, Diphtheria, Pertussis, and Tetanus (DPT), Polio Hepatitis, Measles, Mumps, and Rubella (MMR), Other Indications), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Global Outlook to 2026
Report ID: 392058 | May 2020 | No. of Pages: 120
|
Covid-19 Impact Analysis & Forecast
Global Vaccines Market size is estimated to record USD 68.73 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 7.4%.
Vaccines Market report (2019-2026) includes global market size, trends, company overview, competition analysis, and forecast. The global market is projected to record USD 41.7 Billion in 2019.
The market report includes Vaccines market definition, segmentation, executive summary, value chain analysis, porter’s analysis, research methodology and new industry trends which includes drivers, restraints and market opportunities. Other section includes regional analysis which is conducted on various factors such as cost of the product/services, raw material supplies, production capacities, availability and demand analysis. Further section includes analysis and opportunity assessment for key companies. This section includes competition analysis, market share analysis, key developments of the industry, and company profiling. Within company profiling, detailed analysis of key players including company overview, financial information analysis, product offerings, and recent development of company. This also includes SWOT analysis that highlights the current position of company among competitors and in market.
Vaccines Market Dynamics
The market report comprises of market dynamics/trends section that includes driving factors, restraints, and opportunities faced by the market players and stakeholders. These market trends includes core factors such as driving factor and restraining factor and extrinsic factors such as opportunities. These factors are not only confined with the current market situation as well as with the forecasted period.
Vaccines Market Competitive Landscape
The key companies in Vaccines Market are Astellas Pharma Inc., Astrazeneca Plc. (Medimmune, LLC.), CSL Limited, Emergent Biosolutions, Inc., Glaxosmithkline Plc., Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Sanofi Pasteur, Serum Institute of India Pvt. Ltd..
Focus Areas of Market
• Global Market Analysis (2019-2026)
• Cost Analysis
• Market Growth Factors
• Market Strategies
• Key Companies Analysis
• Industry Growth Analysis
Regional Analysis
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa
Company Profile Inclusions
• Business Overview
• Financial Information
• Market Share Analysis
• Recent News
• SWOT Analysis
Vaccines Market report (2019-2026) includes global market size, trends, company overview, competition analysis, and forecast. The global market is projected to record USD 41.7 Billion in 2019.
The market report includes Vaccines market definition, segmentation, executive summary, value chain analysis, porter’s analysis, research methodology and new industry trends which includes drivers, restraints and market opportunities. Other section includes regional analysis which is conducted on various factors such as cost of the product/services, raw material supplies, production capacities, availability and demand analysis. Further section includes analysis and opportunity assessment for key companies. This section includes competition analysis, market share analysis, key developments of the industry, and company profiling. Within company profiling, detailed analysis of key players including company overview, financial information analysis, product offerings, and recent development of company. This also includes SWOT analysis that highlights the current position of company among competitors and in market.
Vaccines Market Dynamics
The market report comprises of market dynamics/trends section that includes driving factors, restraints, and opportunities faced by the market players and stakeholders. These market trends includes core factors such as driving factor and restraining factor and extrinsic factors such as opportunities. These factors are not only confined with the current market situation as well as with the forecasted period.
Vaccines Market Competitive Landscape
The key companies in Vaccines Market are Astellas Pharma Inc., Astrazeneca Plc. (Medimmune, LLC.), CSL Limited, Emergent Biosolutions, Inc., Glaxosmithkline Plc., Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Sanofi Pasteur, Serum Institute of India Pvt. Ltd..
Focus Areas of Market
• Global Market Analysis (2019-2026)
• Cost Analysis
• Market Growth Factors
• Market Strategies
• Key Companies Analysis
• Industry Growth Analysis
Regional Analysis
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa
Company Profile Inclusions
• Business Overview
• Financial Information
• Market Share Analysis
• Recent News
• SWOT Analysis
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
Chapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain Analysis
Chapter 5. Vaccines Industry, By Technology
5.1. Vaccines Market, By Technology 2019-2026
5.2. Conjugate Vaccines
5.3. Inactivated Vaccines
5.4. Live Attenuated Vaccines
5.5. Toxoid Vaccines
5.6. Recombinant Vaccines
5.7. Other Vaccines
Chapter 6. Vaccines Industry, By Indication
6.1. Vaccines Market, By Indication 2019-2026
6.2. Pneumococcal Disease
6.3. Influenza
6.4. Human Papilloma Virus
6.5. Meningococcal Disease
6.6. Rotavirus
6.7. Varicella
6.8. Diphtheria, Pertussis, and Tetanus (DPT)
6.9. Polio
6.10. Hepatitis
6.11. Measles, Mumps, and Rubella (MMR)
6.12. Other Indications
Chapter 7. Vaccines Industry, By Region
7.1. Vaccines Market, By Region 2019-2026
7.1.1. North America
7.1.1.1. U.S
7.1.1.1. Canada
7.1.1.2. Mexico
7.1.2. Europe
7.1.2.1. U.K.
7.1.2.2. Germany
7.1.2.3. France
7.1.2.4. Rest of the Europe
7.1.3. Middle East & Africa (MEA)
7.1.3.1. GCC
7.1.3.2. North Africa
7.1.3.3. South Africa
7.1.3.4. Rest of MEA
7.1.4. Latin America (LATAM)
7.1.4.1. Brazil
7.1.4.2. Rest of LATAM
7.1.5. Asia Pacific (APAC)
7.1.5.1. India
7.1.5.2. China
7.1.5.3. Japan
7.1.5.4. Rest of the APAC
Chapter 8. Competitive Landscape
8.1.1. Key Strategies Adopted by Players
8.1.2. Market Share/Positioning Analysis
Chapter 9. Company Profiles
9.1. Astellas Pharma Inc.
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Astrazeneca Plc. (Medimmune, LLC.)
9.3. CSL Limited
9.4. Emergent Biosolutions, Inc.
9.5. Glaxosmithkline Plc.
9.6. Johnson & Johnson
9.7. Merck & Co., Inc.
9.8. Pfizer Inc.
9.9. Sanofi Pasteur
9.10. Serum Institute of India Pvt. Ltd.
Chapter 10. Appendix
10.1. About Us
10.2. Glossary of Terms
10.3. Disclaimer
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
Chapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain Analysis
Chapter 5. Vaccines Industry, By Technology
5.1. Vaccines Market, By Technology 2019-2026
5.2. Conjugate Vaccines
5.3. Inactivated Vaccines
5.4. Live Attenuated Vaccines
5.5. Toxoid Vaccines
5.6. Recombinant Vaccines
5.7. Other Vaccines
Chapter 6. Vaccines Industry, By Indication
6.1. Vaccines Market, By Indication 2019-2026
6.2. Pneumococcal Disease
6.3. Influenza
6.4. Human Papilloma Virus
6.5. Meningococcal Disease
6.6. Rotavirus
6.7. Varicella
6.8. Diphtheria, Pertussis, and Tetanus (DPT)
6.9. Polio
6.10. Hepatitis
6.11. Measles, Mumps, and Rubella (MMR)
6.12. Other Indications
Chapter 7. Vaccines Industry, By Region
7.1. Vaccines Market, By Region 2019-2026
7.1.1. North America
7.1.1.1. U.S
7.1.1.1. Canada
7.1.1.2. Mexico
7.1.2. Europe
7.1.2.1. U.K.
7.1.2.2. Germany
7.1.2.3. France
7.1.2.4. Rest of the Europe
7.1.3. Middle East & Africa (MEA)
7.1.3.1. GCC
7.1.3.2. North Africa
7.1.3.3. South Africa
7.1.3.4. Rest of MEA
7.1.4. Latin America (LATAM)
7.1.4.1. Brazil
7.1.4.2. Rest of LATAM
7.1.5. Asia Pacific (APAC)
7.1.5.1. India
7.1.5.2. China
7.1.5.3. Japan
7.1.5.4. Rest of the APAC
Chapter 8. Competitive Landscape
8.1.1. Key Strategies Adopted by Players
8.1.2. Market Share/Positioning Analysis
Chapter 9. Company Profiles
9.1. Astellas Pharma Inc.
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Astrazeneca Plc. (Medimmune, LLC.)
9.3. CSL Limited
9.4. Emergent Biosolutions, Inc.
9.5. Glaxosmithkline Plc.
9.6. Johnson & Johnson
9.7. Merck & Co., Inc.
9.8. Pfizer Inc.
9.9. Sanofi Pasteur
9.10. Serum Institute of India Pvt. Ltd.
Chapter 10. Appendix
10.1. About Us
10.2. Glossary of Terms
10.3. Disclaimer
1. Astellas Pharma Inc.
2. Astrazeneca Plc. (Medimmune, LLC.)
3. CSL Limited
4. Emergent Biosolutions, Inc.
5. Glaxosmithkline Plc.
6. Johnson & Johnson
7. Merck & Co., Inc.
8. Pfizer Inc.
9. Sanofi Pasteur
10. Serum Institute of India Pvt. Ltd.
2. Astrazeneca Plc. (Medimmune, LLC.)
3. CSL Limited
4. Emergent Biosolutions, Inc.
5. Glaxosmithkline Plc.
6. Johnson & Johnson
7. Merck & Co., Inc.
8. Pfizer Inc.
9. Sanofi Pasteur
10. Serum Institute of India Pvt. Ltd.
Connect With Us
+1-707-633-0404
sales@search4research.com
Related reports
|
|
(COVID Version) Global Cotton Buds Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 105
|
$3000Buy Now |
|
|
(COVID Version) Global Cotton Balls and Swabs Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 110
|
$3000Buy Now |
|
|
(COVID Version) Global Cosmetic Surgery Equipment Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 108
|
$3000Buy Now |
|
|
(COVID Version) Global Cosmetic Prostheses Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 100
|
$3000Buy Now |
|
|
(COVID Version) Global Cortisone Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 103
|
$3000Buy Now |